Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says – Sydney Morning Herald

Jakarta: Indonesia’s state-owned pharmaceutical company Bio Farma said on Tuesday that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy.
“Our clinical trial team found, within one month, that the interim data shows up to 97 per cent for its efficacy,” said Iwan Setiawan, a spokesman for Bio Farma, at a news conference.
Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its…

Click here to view the original article.